2025 Q4 -tulosraportti
Vain PDF
56 päivää sitten
0,0823 SEK/osake
Viimeisin osinko
0,00%Tuotto/v
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 26.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 27.11.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 28.5.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·23 t sittenReally several percent down if one is to sell just a few thousand shares SO THE PRICE MANIPULATION IS COMPLETELY INTACT
·22 t sittenThey do not acquire shares, only manipulate the price by placing buy/sell orders and removing them again without any trades occurring at that price. Is that allowed?·21 t sittenYes, there's some trading going on, but it's clear that some are working in concert. Types like Stig b and podium are very clear examples that they want to manipulate the price and they try to move the price. Short sellers and fake analyses from various AI posts, NN and not least FI, I believe are also involved in this. Management was quick to state "still not approved" which cost 60% of the share price, but NO ONE from Saniona thinks anything is wrong even though we are 50% down in a few months 🥱. We probably have to admit that jd and the megalomania together with rami have cost a lot of trust in the stock, even though TF has done something good, communication is simply non-existent from management and there is no interest in proper analyses either, they thought redeye was fantastic, both when they had 100+ as a price target and now after the agreements have something around 7-16 and teso thinks they are worth approx 70 øre. It will probably end up okay in a few years, but the economically criminal scoundrels are the reason "bandits in suits" was invented.
·1 päivä sittenStig B. Try to take a look at Ascelia, Gentian and Observe Medicals
·1 päivä sittenHmm - as a high risk/reward position, Observe could be a bit fun, if they can partially reclaim the Convatec market. Sounds like a bit of a task, though, and it also seems that execution power is low - both resource-wise and experience-wise when looking at the organization (management, size, and board). I'll have to look into that a bit more - but it sounds fun/exciting. Gantian, I need to look into a bit more - it seems to be more of a "proven case".- ·1 päivä sitten · MuokattuThere's quite a hard fight against the "market" to keep it above 15.00 - they're trying everything - 1-100 pcs at the lowest selling price to briefly give it a "hop". Quite silly to take 45 pcs at 15.26, when the last trade was at 15.11 :-). Gross "manipulation" :-) to prevent me from getting the last ones within my buying window of 12-15, where it rightfully belongs at the moment :-) :-). A tough battle is being fought between "fantasists" and "realists" - the "fantasists" briefly had the upper hand for a few months, but it looks like the "realists" have fought their way back into the fight - incredibly exciting to follow :-). Got quite annoyed yesterday, so was "tempted" to take a chunk at 15.06 - but I think maybe today I can get another chunk between 14.5 and 15.00 - it's unlikely to go down further before Medix finally gives up on Tesofensine or Cofepris rejects it again - I just need to make room to grab the last ones I want at the current risk level in Saninoa's pipeline. Otherwise, there's been good progress with those I considered more exciting in the 6-12 month term, and where some of the Saniona proceeds from Oct-Jan were placed (Infant Bacterial, Moberg, AcuCort, Xvivo, Vicore, Egetis - Hansa is still lagging a bit).
·1 päivä sittenChit-chat. Empty barrels………. Your buying window changes quite quickly. 10/4 it was 15-25, now it is 12-15. As long as you don't dare to show your portfolio……..I would say the first one fits best,,,,,,empty…….
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
Vain PDF
56 päivää sitten
0,0823 SEK/osake
Viimeisin osinko
0,00%Tuotto/v
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·23 t sittenReally several percent down if one is to sell just a few thousand shares SO THE PRICE MANIPULATION IS COMPLETELY INTACT·22 t sittenThey do not acquire shares, only manipulate the price by placing buy/sell orders and removing them again without any trades occurring at that price. Is that allowed?·21 t sittenYes, there's some trading going on, but it's clear that some are working in concert. Types like Stig b and podium are very clear examples that they want to manipulate the price and they try to move the price. Short sellers and fake analyses from various AI posts, NN and not least FI, I believe are also involved in this. Management was quick to state "still not approved" which cost 60% of the share price, but NO ONE from Saniona thinks anything is wrong even though we are 50% down in a few months 🥱. We probably have to admit that jd and the megalomania together with rami have cost a lot of trust in the stock, even though TF has done something good, communication is simply non-existent from management and there is no interest in proper analyses either, they thought redeye was fantastic, both when they had 100+ as a price target and now after the agreements have something around 7-16 and teso thinks they are worth approx 70 øre. It will probably end up okay in a few years, but the economically criminal scoundrels are the reason "bandits in suits" was invented.
- ·1 päivä sittenStig B. Try to take a look at Ascelia, Gentian and Observe Medicals·1 päivä sittenHmm - as a high risk/reward position, Observe could be a bit fun, if they can partially reclaim the Convatec market. Sounds like a bit of a task, though, and it also seems that execution power is low - both resource-wise and experience-wise when looking at the organization (management, size, and board). I'll have to look into that a bit more - but it sounds fun/exciting. Gantian, I need to look into a bit more - it seems to be more of a "proven case".
- ·1 päivä sitten · MuokattuThere's quite a hard fight against the "market" to keep it above 15.00 - they're trying everything - 1-100 pcs at the lowest selling price to briefly give it a "hop". Quite silly to take 45 pcs at 15.26, when the last trade was at 15.11 :-). Gross "manipulation" :-) to prevent me from getting the last ones within my buying window of 12-15, where it rightfully belongs at the moment :-) :-). A tough battle is being fought between "fantasists" and "realists" - the "fantasists" briefly had the upper hand for a few months, but it looks like the "realists" have fought their way back into the fight - incredibly exciting to follow :-). Got quite annoyed yesterday, so was "tempted" to take a chunk at 15.06 - but I think maybe today I can get another chunk between 14.5 and 15.00 - it's unlikely to go down further before Medix finally gives up on Tesofensine or Cofepris rejects it again - I just need to make room to grab the last ones I want at the current risk level in Saninoa's pipeline. Otherwise, there's been good progress with those I considered more exciting in the 6-12 month term, and where some of the Saniona proceeds from Oct-Jan were placed (Infant Bacterial, Moberg, AcuCort, Xvivo, Vicore, Egetis - Hansa is still lagging a bit).·1 päivä sittenChit-chat. Empty barrels………. Your buying window changes quite quickly. 10/4 it was 15-25, now it is 12-15. As long as you don't dare to show your portfolio……..I would say the first one fits best,,,,,,empty…….
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 26.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 27.11.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 28.5.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
2025 Q4 -tulosraportti
Vain PDF
56 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 26.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 27.11.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 28.5.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
0,0823 SEK/osake
Viimeisin osinko
0,00%Tuotto/v
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·23 t sittenReally several percent down if one is to sell just a few thousand shares SO THE PRICE MANIPULATION IS COMPLETELY INTACT·22 t sittenThey do not acquire shares, only manipulate the price by placing buy/sell orders and removing them again without any trades occurring at that price. Is that allowed?·21 t sittenYes, there's some trading going on, but it's clear that some are working in concert. Types like Stig b and podium are very clear examples that they want to manipulate the price and they try to move the price. Short sellers and fake analyses from various AI posts, NN and not least FI, I believe are also involved in this. Management was quick to state "still not approved" which cost 60% of the share price, but NO ONE from Saniona thinks anything is wrong even though we are 50% down in a few months 🥱. We probably have to admit that jd and the megalomania together with rami have cost a lot of trust in the stock, even though TF has done something good, communication is simply non-existent from management and there is no interest in proper analyses either, they thought redeye was fantastic, both when they had 100+ as a price target and now after the agreements have something around 7-16 and teso thinks they are worth approx 70 øre. It will probably end up okay in a few years, but the economically criminal scoundrels are the reason "bandits in suits" was invented.
- ·1 päivä sittenStig B. Try to take a look at Ascelia, Gentian and Observe Medicals·1 päivä sittenHmm - as a high risk/reward position, Observe could be a bit fun, if they can partially reclaim the Convatec market. Sounds like a bit of a task, though, and it also seems that execution power is low - both resource-wise and experience-wise when looking at the organization (management, size, and board). I'll have to look into that a bit more - but it sounds fun/exciting. Gantian, I need to look into a bit more - it seems to be more of a "proven case".
- ·1 päivä sitten · MuokattuThere's quite a hard fight against the "market" to keep it above 15.00 - they're trying everything - 1-100 pcs at the lowest selling price to briefly give it a "hop". Quite silly to take 45 pcs at 15.26, when the last trade was at 15.11 :-). Gross "manipulation" :-) to prevent me from getting the last ones within my buying window of 12-15, where it rightfully belongs at the moment :-) :-). A tough battle is being fought between "fantasists" and "realists" - the "fantasists" briefly had the upper hand for a few months, but it looks like the "realists" have fought their way back into the fight - incredibly exciting to follow :-). Got quite annoyed yesterday, so was "tempted" to take a chunk at 15.06 - but I think maybe today I can get another chunk between 14.5 and 15.00 - it's unlikely to go down further before Medix finally gives up on Tesofensine or Cofepris rejects it again - I just need to make room to grab the last ones I want at the current risk level in Saninoa's pipeline. Otherwise, there's been good progress with those I considered more exciting in the 6-12 month term, and where some of the Saniona proceeds from Oct-Jan were placed (Infant Bacterial, Moberg, AcuCort, Xvivo, Vicore, Egetis - Hansa is still lagging a bit).·1 päivä sittenChit-chat. Empty barrels………. Your buying window changes quite quickly. 10/4 it was 15-25, now it is 12-15. As long as you don't dare to show your portfolio……..I would say the first one fits best,,,,,,empty…….
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Välittäjätilasto
Dataa ei löytynyt